Exelixis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.About EXEL
Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
EXEL Key Statistics
Stock Snapshot
The current Exelixis(EXEL) stock price is $68.73, with a market capitalization of 16.77B. The stock trades at a price-to-earnings (P/E) ratio of 21.16.
During the trading session on 2026-11-13, Exelixis(EXEL) shares reached a daily high of $70.11 and a low of $68.70. At a current price of $68.73, the stock is +0.0% higher than the low and still -2.0% under the high.
Trading volume for Exelixis(EXEL) stock has reached 338.74K, versus its average volume of 3.82M.
Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $73.69 and a low of $39.71.
Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $73.69 and a low of $39.71.
EXEL News
A decade ago, Exelixis (EXEL -1.22%) was just beginning its growth story with the launch of its star cancer treatment Cabometyx. This first indication was in ki...
Morgan Stanley lowered the firm’s price target on Exelixis (EXEL) to $57 from $60 and keeps an Equal Weight rating on the shares. The firm adjusted estimates an...
Exelixis reported third quarter 2026 revenue of US$658.7 million and net income of US$218.1 million, alongside nine month revenue of US$1.8982 billion and net i...
Analyst ratings
58%
of 19 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.